1. giovannriveracot
2. 2thwardz
3. matthewsmelt6
4. carter0
5. shiryteach
1.shawngill0789 03/05/2018
YOU SAY!? - Jefferies raises price target to $46 from $30
2.2thwardz 01/26/2018
So good
3.matthewsmelt6 05/08/2018
Atara Biotherapeutics Expands T-Cell Immunotherapy Collaboration to Advance Next-Generation CAR T Technologies in Oncology, Autoimmune and Other Diseases
4.giovannriveracot 01/04/2018
Secondary killing the stock today
5.carter0 03/05/2018
6.giovannriveracot 01/26/2018
Wowza! 2018 has been hot!
7.2thwardz 02/27/2018
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Progress
8.giovannriveracot 03/05/2018
Nice buy {Image}
9.giovannriveracot 01/26/2018
Cowen & Company initiates as an outperform
10.carter0 05/17/2018
Atara Biotherapeutics to Present Long-Term Tab-cel™ Phase 2 Clinical Outcomes for Patients with Epstein-Barr Virus Associated Post-Transplant Lymphomas at 23rd Congress of European Hematology Associat
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW